Jana Beicht
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity.
Journal: Emerging microbes & infections
Published: August 12, 2024
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice.
Journal: Emerging microbes & infections
Published: July 01, 2024
Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins.
Journal: NPJ vaccines
Published: March 22, 2024
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection.
Journal: Vaccines
Published: November 29, 2023
A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection.
Journal: Frontiers in immunology
Published: March 09, 2023
Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice.
Journal: Frontiers in immunology
Published: March 01, 2023
Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection.
Journal: Frontiers in immunology
Published: December 30, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026